RK

Ravikant Kumar

Active Director Director DIN 09719156
DIN 09719156 First appointment Aug 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value •••• Premium profile

About Ravikant Kumar

Data last updated:

Ravikant Kumar is a Director at Promethus Pharma Private Limited (since 2022). The company operates in Chemicals. Promethus Pharma Private Limited reported revenue of ₹6.2 Lakh (FY 2023).

DIN 09719156
Primary Designation Director
Industry Chemicals
First Appointment 29 Aug 2022
Oldest Company Age 4 yrs
Largest company Promethus Pharma Private Limited · ₹6.2 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Promethus Pharma Private Limited U24100BR2022PTC059655
Director29 Aug 20222022₹6.2 Lakh (FY 2023)Active

Board colleagues of Ravikant Kumar

Directorship timeline

Open interactive timeline →
Promethus Pharma Private Limited
Premium access

Shareholding and investment profile for Ravikant Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravikant Kumar

Ravikant Kumar currently holds 1 directorship: Promethus Pharma Private Limited (Director, since 29 Aug 2022, revenue ₹6.2 Lakh (FY 2023)).

Ravikant Kumar was first appointed on 29 Aug 2022 as Director at Promethus Pharma Private Limited.

The current boards of Ravikant Kumar's companies include Nirmala Verma (Promethus Pharma Private Limited), Ranjan Kumar (Promethus Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available